{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:46:52Z","timestamp":1791193612747,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1755-8794-6-39","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T15:59:11Z","timestamp":1381507151000},"source":"Crossref","is-referenced-by-count":26,"title":["Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes"],"prefix":"10.1186","volume":"6","author":[{"given":"Ewa","family":"Szalowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Stoopen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter JM","family":"Hendriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad ACM","family":"Peijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"issue":"3","key":"413_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1517\/14740338.2.3.287","volume":"2","author":"LS Velayudham","year":"2003","unstructured":"Velayudham LS, Farrell GC: Drug-induced cholestasis. Expert Opin Drug Saf. 2003, 2 (3): 287-304. 10.1517\/14740338.2.3.287.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"413_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B: Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009, 89 (1): 147-191. 10.1152\/physrev.00010.2008.","journal-title":"Physiol Rev"},{"issue":"3","key":"413_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.trim.2010.04.007","volume":"23","author":"M Dandel","year":"2010","unstructured":"Dandel M, Lehmkuhl HB, Knosalla C, Hetzer R: Impact of different long-term maintenance immunosuppressive therapy strategies on patients\u2019 outcome after heart transplantation. Transpl Immunol. 2010, 23 (3): 93-103. 10.1016\/j.trim.2010.04.007.","journal-title":"Transpl Immunol"},{"issue":"3","key":"413_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.toxlet.2013.06.236","volume":"221","author":"AS Kienhuis","year":"2013","unstructured":"Kienhuis AS, Vitins AP, Pennings JL, Pronk TE, Speksnijder EN, Roodbergen M, van Delft JH, Luijten M, van der Ven LT: Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis. Toxicol Lett. 2013, 221 (3): 225-236. 10.1016\/j.toxlet.2013.06.236.","journal-title":"Toxicol Lett"},{"issue":"1","key":"413_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3181\/00379727-199-43328","volume":"199","author":"CO Abernathy","year":"1992","unstructured":"Abernathy CO, Zimmerman HJ, Ishak KG, Utili R, Gillespie J: Drug-induced cholestasis in the perfused rat liver and its reversal by tauroursodeoxycholate: an ultrastructural study. Proc Soc Exp Biol Med. 1992, 199 (1): 54-58. 10.3181\/00379727-199-43328.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"8","key":"413_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/07853890410018916","volume":"36","author":"VE Carlton","year":"2004","unstructured":"Carlton VE, Pawlikowska L, Bull LN: Molecular basis of intrahepatic cholestasis. Ann Med. 2004, 36 (8): 606-617. 10.1080\/07853890410018916.","journal-title":"Ann Med"},{"issue":"9","key":"413_CR7","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1172\/JCI2962","volume":"102","author":"KD Setchell","year":"1998","unstructured":"Setchell KD, Schwarz M, O'Connell NC, Lund EG, Davis DL, Lathe R, Thompson HR, Weslie TR, Sokol RJ, Russell DW: Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest. 1998, 102 (9): 1690-1703. 10.1172\/JCI2962.","journal-title":"J Clin Invest"},{"issue":"25","key":"413_CR8","first-page":"3322","volume":"18","author":"N Hadzic","year":"2012","unstructured":"Hadzic N, Bull LN, Clayton PT, Knisely AS: Diagnosis in bile acid-CoA: amino acid N-acyltransferase deficiency. World J Gastroenterol. 2012, 18 (25): 3322-3326.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"413_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.pharmthera.2010.03.005","volume":"126","author":"G Zollner","year":"2010","unstructured":"Zollner G, Wagner M, Trauner M: Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol Ther. 2010, 126 (3): 228-243. 10.1016\/j.pharmthera.2010.03.005.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"413_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","volume":"58","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic E, Claudel T, Trauner M: Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol. 2013, 58 (1): 155-68. 10.1016\/j.jhep.2012.08.002.","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"413_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cbi.2006.06.007","volume":"163","author":"GE Kass","year":"2006","unstructured":"Kass GE: Mitochondrial involvement in drug-induced hepatic injury. Chem Biol Interact. 2006, 163 (1\u20132): 145-159.","journal-title":"Chem Biol Interact"},{"issue":"10","key":"413_CR12","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/ncpgasthep0602","volume":"3","author":"A Geier","year":"2006","unstructured":"Geier A, Fickert P, Trauner M: Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol. 2006, 3 (10): 574-585. 10.1038\/ncpgasthep0602.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"1","key":"413_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tiv.2010.09.011","volume":"25","author":"AA Khan","year":"2011","unstructured":"Khan AA, Chow EC, Porte RJ, Pang KS, Groothuis GM: The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices. ToxicolIn Vitro. 2011, 25 (1): 80-90. 10.1016\/j.tiv.2010.09.011.","journal-title":"ToxicolIn Vitro"},{"issue":"3","key":"413_CR14","first-page":"300","volume":"229","author":"MG Elferink","year":"2008","unstructured":"Elferink MG, Olinga P, Draaisma AL, Merema MT, Bauerschmidt S, Polman J, Schoonen WG, Groothuis GM: Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity. ToxicolApplPharmacol. 2008, 229 (3): 300-309.","journal-title":"ToxicolApplPharmacol"},{"issue":"2","key":"413_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","volume":"31","author":"MF Silva","year":"2008","unstructured":"Silva MF, Aires CC, Luis PB, Ruiter JP, IJlst L, Duran M, Wanders RJ, Tavares de Almeida I: Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis. 2008, 31 (2): 205-216. 10.1007\/s10545-008-0841-x.","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"413_CR16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","volume":"298","author":"P Vassallo","year":"2007","unstructured":"Vassallo P, Trohman RG: Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007, 298 (11): 1312-1322. 10.1001\/jama.298.11.1312.","journal-title":"JAMA"},{"issue":"5","key":"413_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1172\/JCI109754","volume":"65","author":"RF Burk","year":"1980","unstructured":"Burk RF, Lawrence RA, Lane JM: Liver necrosis and lipid peroxidation in the rat as the result of paraquat and diquat administration. Effect of selenium deficiency. J Clin Invest. 1980, 65 (5): 1024-1031. 10.1172\/JCI109754.","journal-title":"J Clin Invest"},{"issue":"2","key":"413_CR18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)32069-0","volume":"213","author":"JA Timbrell","year":"1980","unstructured":"Timbrell JA, Mitchell JR, Snodgrass WR, Nelson SD: Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo. J Pharmacol Exp Ther. 1980, 213 (2): 364-369.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"413_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1439-0442.2007.00927.x","volume":"54","author":"MJ Groot","year":"2007","unstructured":"Groot MJ, Ossenkoppele JS, Bakker R, Pfaffl MW, Meyer HH, Nielen MW: Reference histology of veal calf genital and endocrine tissues - an update for screening on hormonal growth promoters. J Vet Med A Physiol Pathol Clin Med. 2007, 54 (5): 238-246. 10.1111\/j.1439-0442.2007.00927.x.","journal-title":"J Vet Med A Physiol Pathol Clin Med"},{"key":"413_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1471-2105-11-211","volume":"11","author":"Y Qu","year":"2010","unstructured":"Qu Y, He F, Chen Y: Different effects of the probe summarization algorithms PLIER and RMA on high-level analysis of Affymetrix exon arrays. BMC Bioinformatics. 2010, 11: 211-10.1186\/1471-2105-11-211.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"413_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.taap.2012.01.009","volume":"259","author":"MJ Jetten","year":"2012","unstructured":"Jetten MJ, Gaj S, Ruiz-Aracama A, de Kok TM, van Delft JH, Lommen A, van Someren EP, Jennen DG, Claessen SM, Peijnenburg AA, et al: Omics analysis of low dose acetaminophen intake demonstrates novel response pathways in humans. Toxicol Appl Pharmacol. 2012, 259 (3): 320-328. 10.1016\/j.taap.2012.01.009.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"43","key":"413_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005, 102 (43): 15545-15550. 10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"413_CR23","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/gb-2008-9-6-r96","volume":"9","author":"R Jelier","year":"2008","unstructured":"Jelier R, Schuemie MJ, Veldhoven A, Dorssers LC, Jenster G, Kors JA: Anni 2.0: a multipurpose text-mining tool for the life sciences. Genome Biol. 2008, 9 (6): R96-10.1186\/gb-2008-9-6-r96.","journal-title":"Genome Biol"},{"issue":"Database issue","key":"413_CR24","first-page":"D808\u2013815","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al: STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013, 41 (Database issue): D808\u2013815.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"413_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"1","key":"413_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/toxsci\/kfq380","volume":"120","author":"A van Summeren","year":"2011","unstructured":"van Summeren A, Renes J, Bouwman FG, Noben JP, van Delft JH, Kleinjans JC, Mariman EC: Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci. 2011, 120 (1): 109-122. 10.1093\/toxsci\/kfq380.","journal-title":"Toxicol Sci"},{"issue":"4","key":"413_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cmet.2007.03.002","volume":"5","author":"S Gray","year":"2007","unstructured":"Gray S, Wang B, Orihuela Y, Hong EG, Fisch S, Haldar S, Cline GW, Kim JK, Peroni OD, Kahn BB, et al: Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metab. 2007, 5 (4): 305-312. 10.1016\/j.cmet.2007.03.002.","journal-title":"Cell Metab"},{"issue":"7","key":"413_CR28","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1096\/fj.11-195701","volume":"26","author":"B Renga","year":"2012","unstructured":"Renga B, Mencarelli A, D'Amore C, Cipriani S, Baldelli F, Zampella A, Distrutti E, Fiorucci S: Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. FASEB J. 2012, 26 (7): 3021-3031. 10.1096\/fj.11-195701.","journal-title":"FASEB J"},{"issue":"1","key":"413_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000282091","volume":"28","author":"M Trauner","year":"2010","unstructured":"Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M: Bile acids as regulators of hepatic lipid and glucose metabolism. J Dig Dis. 2010, 28 (1): 220-224. 10.1159\/000282091.","journal-title":"J Dig Dis"},{"issue":"1","key":"413_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.etp.2006.04.003","volume":"58","author":"A Barth","year":"2006","unstructured":"Barth A, Braun J, Muller D: Influence of Verapamil and Cyclosporin A on bile acid metabolism and transport in rat liver slices. Exp Toxicol Pathol. 2006, 58 (1): 31-37. 10.1016\/j.etp.2006.04.003.","journal-title":"Exp Toxicol Pathol"},{"issue":"5 Pt 1","key":"413_CR31","first-page":"G613","volume":"253","author":"RW Van Dyke","year":"1987","unstructured":"Van Dyke RW, Scharschmidt BF: Effects of chlorpromazine on Na + \u2212K + \u2212ATPase pumping and solute transport in rat hepatocytes. Am J Physiol. 1987, 253 (5 Pt 1): G613-G621.","journal-title":"Am J Physiol"},{"issue":"1","key":"413_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00204-012-0924-1","volume":"87","author":"M Hadi","year":"2013","unstructured":"Hadi M, Dragovic S, van Swelm R, Herpers B, van de Water B, Russel FG, Commandeur JN, Groothuis GM: AMAP, the alleged non-toxic isomer of acetaminophen, is toxic in rat and human liver. Arch Toxicol. 2013, 87 (1): 155-165. 10.1007\/s00204-012-0924-1.","journal-title":"Arch Toxicol"},{"issue":"4","key":"413_CR33","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.tiv.2008.02.001","volume":"22","author":"K Jemnitz","year":"2008","unstructured":"Jemnitz K, Veres Z, Monostory K, Kobori L, Vereczkey L: Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes. Toxicol In Vitro. 2008, 22 (4): 961-967. 10.1016\/j.tiv.2008.02.001.","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"413_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0024-3205(03)00292-3","volume":"73","author":"F Chanussot","year":"2003","unstructured":"Chanussot F, Benkoel L: Prevention by dietary (n-6) polyunsaturated phosphatidylcholines of intrahepatic cholestasis induced by cyclosporine A in animals. Life Sci. 2003, 73 (4): 381-392. 10.1016\/S0024-3205(03)00292-3.","journal-title":"Life Sci"},{"issue":"4","key":"413_CR35","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.26160","volume":"57","author":"S Antherieu","year":"2013","unstructured":"Antherieu S, Bachour-El Azzi P, Dumont J, Abdel-Razzak Z, Guguen-Guillouzo C, Fromenty B, Robin MA, Guillouzo A: Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology. 2013, 57 (4): 1518-1529. 10.1002\/hep.26160.","journal-title":"Hepatology"},{"issue":"6","key":"413_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","volume":"102","author":"CJ Sinal","year":"2000","unstructured":"Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ: Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis. Cell. 2000, 102 (6): 731-744. 10.1016\/S0092-8674(00)00062-3.","journal-title":"Cell"},{"issue":"4","key":"413_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/jat.1420","volume":"29","author":"H Fujimura","year":"2009","unstructured":"Fujimura H, Murakami N, Kurabe M, Toriumi W: In vitro assay for drug-induced hepatosteatosis using rat primary hepatocytes, a fluorescent lipid analog and gene expression analysis. J Appl Toxicol. 2009, 29 (4): 356-363. 10.1002\/jat.1420.","journal-title":"J Appl Toxicol"},{"issue":"10","key":"413_CR38","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1517\/17425255.2012.709500","volume":"8","author":"TC Delgado","year":"2012","unstructured":"Delgado TC, Barosa C, Nunes PM, Scott DK, O'Doherty RM, Cerdan S, Geraldes CF, Jones JG: Effect of cyclosporine A on hepatic carbohydrate metabolism and hepatic gene expression in rat. Expert Opin Drug Metab Toxicol. 2012, 8 (10): 1223-1230. 10.1517\/17425255.2012.709500.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"413_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.2042-7158.1998.tb06884.x","volume":"50","author":"M Shin","year":"1998","unstructured":"Shin M, Asada S, Mizumori N, Sano K, Umezawa C: Effect of thioridazine or chlorpromazine on increased hepatic NAD + level in rats fed clofibrate, a hypolipidaemic drug. J Pharm Pharmacol. 1998, 50 (4): 431-436. 10.1111\/j.2042-7158.1998.tb06884.x.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"413_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2131\/jts.17.69","volume":"17","author":"K Hoshi","year":"1992","unstructured":"Hoshi K, Fujino S: Difference between effects of chlorpromazine and perphenazine on microsomal phospholipids and enzyme activities in rat liver. J Toxicol Sci. 1992, 17 (2): 69-79. 10.2131\/jts.17.69.","journal-title":"J Toxicol Sci"},{"issue":"5","key":"413_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/labinvest.2011.11","volume":"91","author":"Z Ding","year":"2011","unstructured":"Ding Z, Kng Y, Yang H, Ke Z, Zhuo L: An orally available small imidazolium salt ameliorates inflammation and fibrosis in a murine model of cholestasis. Lab Invest. 2011, 91 (5): 752-763. 10.1038\/labinvest.2011.11.","journal-title":"Lab Invest"},{"issue":"3","key":"413_CR42","first-page":"301","volume":"21","author":"R Rezzani","year":"2006","unstructured":"Rezzani R: Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies. Histol Histopathol. 2006, 21 (3): 301-316.","journal-title":"Histol Histopathol"},{"issue":"3","key":"413_CR43","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0022-3565(24)36544-9","volume":"280","author":"A Wolf","year":"1997","unstructured":"Wolf A, Trendelenburg CF, ez-Fernandez C, Prieto P, Houy S, Trommer WE, Cordier A: Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther. 1997, 280 (3): 1328-1334.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"413_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/08830185.2010.522281","volume":"30","author":"M Kitamura","year":"2011","unstructured":"Kitamura M: Control of NF-kappaB and inflammation by the unfolded protein response. Int Rev Immunol. 2011, 30 (1): 4-15. 10.3109\/08830185.2010.522281.","journal-title":"Int Rev Immunol"},{"issue":"1","key":"413_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000282062","volume":"28","author":"YH Oo","year":"2010","unstructured":"Oo YH, Shetty S, Adams DH: The role of chemokines in the recruitment of lymphocytes to the liver. Dig Dis. 2010, 28 (1): 31-44. 10.1159\/000282062.","journal-title":"Dig Dis"},{"issue":"1\u20132","key":"413_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jim.2012.02.003","volume":"378","author":"M Nascimbeni","year":"2012","unstructured":"Nascimbeni M, Bourdoncle P, Penna C, Saunier B: Recruitment and interaction of human dendritic and T cells in autologous liver slices experimentally infected with HCV produced in cell culture. J Immunol Methods. 2012, 378 (1\u20132): 51-55.","journal-title":"J Immunol Methods"},{"issue":"1","key":"413_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00024382-199901000-00001","volume":"11","author":"A De Maio","year":"1999","unstructured":"De Maio A: Heat shock proteins: facts, thoughts, and dreams. Shock. 1999, 11 (1): 1-12. 10.1097\/00024382-199901000-00001.","journal-title":"Shock"},{"key":"413_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1146\/annurev.cellbio.15.1.799","volume":"15","author":"AE Johnson","year":"1999","unstructured":"Johnson AE, van Waes MA: The translocon: a dynamic gateway at the ER membrane. Annu Rev Cell Dev Biol. 1999, 15: 799-842. 10.1146\/annurev.cellbio.15.1.799.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2 Suppl","key":"413_CR49","doi-asserted-by":"publisher","first-page":"90S","DOI":"10.1097\/00007890-198808001-00017","volume":"46","author":"B Ryffel","year":"1988","unstructured":"Ryffel B, Foxwell BM, Gee A, Greiner B, Woerly G, Mihatsch MJ: Cyclosporine\u2013relationship of side effects to mode of action. Transplantation. 1988, 46 (2 Suppl): 90S-96S.","journal-title":"Transplantation"},{"issue":"1","key":"413_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/hep.1840120114","volume":"12","author":"ID Roman","year":"1990","unstructured":"Roman ID, Monte MJ, Gonzalez-Buitrago JM, Esteller A, Jimenez R: Inhibition of hepatocytary vesicular transport by cyclosporin A in the rat: relationship with cholestasis and hyperbilirubinemia. Hepatology. 1990, 12 (1): 83-91. 10.1002\/hep.1840120114.","journal-title":"Hepatology"},{"issue":"4","key":"413_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1748-1716.1991.tb09254.x","volume":"143","author":"T Veel","year":"1991","unstructured":"Veel T, Villanger O, Holthe MR, Skjorten FS, Raeder MG: Intravenous bilirubin infusion causes vacuolization of the cytoplasm of hepatocytes and canalicular cholestasis. Acta Physiol Scand. 1991, 143 (4): 421-429. 10.1111\/j.1748-1716.1991.tb09254.x.","journal-title":"Acta Physiol Scand"},{"issue":"11","key":"413_CR52","doi-asserted-by":"publisher","first-page":"8988","DOI":"10.1074\/jbc.M212633200","volume":"278","author":"MS Kim","year":"2003","unstructured":"Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C: Repression of farnesoid X receptor during the acute phase response. J Biol Chem. 2003, 278 (11): 8988-8995. 10.1074\/jbc.M212633200.","journal-title":"J Biol Chem"},{"issue":"2","key":"413_CR53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.metabol.2006.10.007","volume":"56","author":"MS Kim","year":"2007","unstructured":"Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, Feingold KR: Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism. 2007, 56 (2): 267-279. 10.1016\/j.metabol.2006.10.007.","journal-title":"Metabolism"},{"issue":"2","key":"413_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.toxlet.2012.08.020","volume":"214","author":"M Auli","year":"2012","unstructured":"Auli M, Domenech A, Andres A, Orta M, Salva M, Descotes J, Prats N: Multiparametric immunotoxicity screening in mice during early drug development. Toxicol Lett. 2012, 214 (2): 200-208. 10.1016\/j.toxlet.2012.08.020.","journal-title":"Toxicol Lett"},{"issue":"6","key":"413_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11938-003-0047-0","volume":"6","author":"S Liangpunsakul","year":"2003","unstructured":"Liangpunsakul S, Chalasani N: Treatment of Nonalcoholic Fatty Liver Disease. Curr Treat Options Gastroenterol. 2003, 6 (6): 455-463. 10.1007\/s11938-003-0047-0.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"3\u20134","key":"413_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.semdp.2006.11.002","volume":"23","author":"WW Yip","year":"2006","unstructured":"Yip WW, Burt AD: Alcoholic liver disease. Semin Diagn Pathol. 2006, 23 (3\u20134): 149-160.","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"413_CR57","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.biocel.2012.06.031","volume":"44","author":"BM Dulmovits","year":"2012","unstructured":"Dulmovits BM, Herman IM: Microvascular remodeling and wound healing: a role for pericytes. Int J Biochem Cell Biol. 2012, 44 (11): 1800-1812. 10.1016\/j.biocel.2012.06.031.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"413_CR58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/jhep.2002.34734","volume":"36","author":"WR Kim","year":"2002","unstructured":"Kim WR, Brown RS, Terrault NA, El-Serag H: Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002, 36 (1): 227-242. 10.1053\/jhep.2002.34734.","journal-title":"Hepatology"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-8794-6-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1755-8794-6-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-8794-6-39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T16:32:54Z","timestamp":1746030774000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/1755-8794-6-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1186\/1755-8794-6-39","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]},"article-number":"39"}}